AmpliPhi Biosciences Corp (APHB) - Financial and Strategic SWOT Analysis Review

May 2018 | 48 pages | ID: A99DE8DFBE9EN
GlobalData

Abstracts

AmpliPhi Biosciences Corp (APHB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AmpliPhi Biosciences Corp (AmpliPhi) is a biotechnology company which focuses on development and commercialization of bacteriophage-based antibacterial therapeutics. The company by utilizing its proprietary bacteriophage technology developed a pipeline of products for the treatment of various antibiotic-resistant bacterial infections. Its pipeline product portfolio includes AB-SA01 for Staphylococcus aureus (S. aureus) infections including methicillin-resistant S. aureus and AB-PA01 for Pseudomonas aeruginosa lung infections in cystic fibrosis patients. It has manufacturing facility in Ljubljana, Slovenia; and a laboratory in Richmond, Virginia and Brookvale, Australia. AmpliPhi is headquartered in San Diego, California, the US.

AmpliPhi Biosciences Corp Key Recent Developments

Mar 14,2018: AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
Dec 14,2017: AmpliPhi Biosciences Provides Corporate and Strategic Update
Nov 14,2017: AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
Sep 06,2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
Aug 14,2017: AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results and Business Highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AmpliPhi Biosciences Corp - Key Facts
AmpliPhi Biosciences Corp - Key Employees
AmpliPhi Biosciences Corp - Key Employee Biographies
AmpliPhi Biosciences Corp - Major Products and Services
AmpliPhi Biosciences Corp - History
AmpliPhi Biosciences Corp - Company Statement
AmpliPhi Biosciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AmpliPhi Biosciences Corp - Business Description
AmpliPhi Biosciences Corp - Corporate Strategy
AmpliPhi Biosciences Corp - SWOT Analysis
SWOT Analysis - Overview
AmpliPhi Biosciences Corp - Strengths
AmpliPhi Biosciences Corp - Weaknesses
AmpliPhi Biosciences Corp - Opportunities
AmpliPhi Biosciences Corp - Threats
AmpliPhi Biosciences Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AmpliPhi Biosciences Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 14, 2018: AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights
Dec 14, 2017: AmpliPhi Biosciences Provides Corporate and Strategic Update
Nov 14, 2017: AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights
Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
Sep 06, 2017: AmpliPhi Biosciences Announces Receipt of $2.0 Million R&D Tax Incentive
Aug 14, 2017: AmpliPhi Biosciences Reports Second Quarter 2017 Financial Results and Business Highlights
Jul 05, 2017: AmpliPhi Biosciences to Present at Bacteriophage Therapy Workshop Sponsored by the FDA and NIH
May 31, 2017: AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer
May 30, 2017: AmpliPhi Biosciences to Present at 7th Annual LD Micro Invitational Conference on June 6
May 15, 2017: AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AmpliPhi Biosciences Corp, Key Facts
AmpliPhi Biosciences Corp, Key Employees
AmpliPhi Biosciences Corp, Key Employee Biographies
AmpliPhi Biosciences Corp, Major Products and Services
AmpliPhi Biosciences Corp, History
AmpliPhi Biosciences Corp, Other Locations
AmpliPhi Biosciences Corp, Subsidiaries
AmpliPhi Biosciences Corp, Key Competitors
AmpliPhi Biosciences Corp, Ratios based on current share price
AmpliPhi Biosciences Corp, Annual Ratios
AmpliPhi Biosciences Corp, Annual Ratios (Cont.1)
AmpliPhi Biosciences Corp, Interim Ratios
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
AmpliPhi Biosciences Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AmpliPhi Biosciences Corp, Performance Chart (2013 - 2017)
AmpliPhi Biosciences Corp, Ratio Charts
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
AmpliPhi Biosciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Synthetic Genomics Inc
Phagelux Inc
LytPhage Inc
Locus Biosciences Inc
iNtRON Biotechnology Inc
Intralytix Inc
EpiBiome Inc
EnBiotix Inc
Biomx Ltd